BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11365480)

  • 1. PEPping up your HIV defenses.
    Torres G
    GMHC Treat Issues; 1998 May; 12(5):8-9. PubMed ID: 11365480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-exposure HIV prevention within and outside the hospital].
    Jost J
    Ther Umsch; 1998 May; 55(5):289-94. PubMed ID: 9643126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with PEP finds most patients stop early.
    AIDS Alert; 1997 Sep; 12(9):101-2. PubMed ID: 11364582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-exposure prevention (PEP); what to do if the condom breaks?
    James JS
    AIDS Treat News; 1998 Sep; (302):1-4. PubMed ID: 11365761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV exposure through contact with body fluids.
    Prescrire Int; 2012 Apr; 21(126):100-1, 103-5. PubMed ID: 22515138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
    Kahn JO; Martin JN; Roland ME; Bamberger JD; Chesney M; Chambers D; Franses K; Coates TJ; Katz MH
    J Infect Dis; 2001 Mar; 183(5):707-14. PubMed ID: 11181146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues on antiretroviral post exposure combination prophylaxis.
    Puro V; Ippolito G
    J Biol Regul Homeost Agents; 1997; 11(1-2):11-9. PubMed ID: 9418155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention.
    AIDS Alert; 1997 Sep; 12(9):97-100. PubMed ID: 11364588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure].
    Sudre P; San Millán Ruiz D; Fagard C; Perrin L; Hirschel BJ
    Schweiz Med Wochenschr; 1999 Feb; 129(8):314-8. PubMed ID: 10189668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical benefits low for non-occupational PEP.
    AIDS Alert; 1997 Sep; 12(9):102-3. PubMed ID: 11364583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postexposure prophylaxis against human immunodeficiency virus.
    Tolle MA; Schwarzwald HL
    Am Fam Physician; 2010 Jul; 82(2):161-6. PubMed ID: 20642270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006.
    Lunding S; Katzenstein TL; Kronborg G; Lindberg JA; Jensen J; Nielsen HI; Pedersen C; Jørgensen LB
    Sex Transm Dis; 2010 Jan; 37(1):49-52. PubMed ID: 19734819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registry finds 3 drugs most favored PEP regimen.
    AIDS Alert; 1998 Jul; 13(7):75-6. PubMed ID: 11365586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS following sexual assault in Jamaican children and adolescents: a case for HIV post-exposure prophylaxis.
    Steel-Duncan JC; Pierre R; Evans-Gilbert T; Rodriquez B; Christie CD
    West Indian Med J; 2004 Oct; 53(5):352-5. PubMed ID: 15675503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study follows PEP for sexual exposures.
    AIDS Alert; 1998 Sep; 13(9):106-7. PubMed ID: 11365790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.